Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Discover which HYD ETF fits best for retirement planning with an eye on income stability and diversification. Learn key factors to compare and start building a resilient retirement portfolio.
22,937 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
I recently allocated just more than $10,000 across three tech stocks to balance growth with risk. Here’s how I chose ...
OKX now lets traders access major US stocks around the clock using cryptocurrency as collateral. The new feature deli...
The median age for first-time buyers climbed to a record 40, with Zillow’s chief executive warning relief from high c...
BlackRock's tokenized BUIDL fund will publish continuous on-chain attestations to back holdings, valuation, and custo...
March’s selling surge has left more than half industry sectors mired in correction territory, prompting fresh bets on...
A surprising move in the stock market drew attention to Super Micro Computer. This article breaks down the forces beh...
A clear, practical guide to interpreting the CWK 2026 earnings transcript. Learn what matters, how to quantify signal...
As Progyny gears up for 2026, investors want clarity on what drives progyny (pgny) 2026 earnings. This guide breaks d...
In 2025, a surprising shift reshaped the starter-home landscape: flippers supplied more starter homes than traditiona...
A quiet, strategic move by a bank’s wealth management arm adds more exposure to its parent company’s stock. Learn wha...
Real Brokerage deepens its Kansas City presence by adding Chartwell Realty, bringing 150 agents and cementing its sta...